
Health Ingredients - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Description
Health Ingredients Market Analysis
The health ingredients market size is estimated at USD 125.90 billion in 2025, and is expected to reach USD 180.54 billion by 2030, at a CAGR of 7.48% during the forecast period (2025-2030). The market's robust expansion is largely attributed to the escalating prevalence of lifestyle-related diseases, surging healthcare costs, and a marked pivot towards preventive care and nutritional wellness. A pivotal moment looms in February 2025, when the FDA's updated definition of "healthy" foods comes into play, opening new avenues for ingredient suppliers who resonate with these elevated nutritional and formulation benchmarks. Within product segmentation, proteins dominate, highlighting their widespread acceptance in wellness and functional offerings. Vitamins, meanwhile, are poised for a notable upswing, driven by a growing awareness of micronutrient deficiencies. The market's sourcing landscape is led by plant-based ingredients, echoing a consumer preference for sustainable and vegan options. Dry formats continue to be favored across diverse applications, yet liquid forms are making a pronounced entrance, praised for their adaptability and superior bioavailability. In terms of application, the food and beverage sector takes the lead, propelled by the rising trend of fortified and functional products. Notably, the pharmaceutical industry is outpacing its counterparts, underscoring a growing inclination to integrate health ingredients into both therapeutic and preventive strategies. Geographically, North America emerges as the dominant player, supported by a discerning, health-focused consumer base and transparent regulatory frameworks. Meanwhile, the Asia-Pacific region is swiftly ascending, driven by increasing incomes, a heightened health consciousness, and rapid urbanization.
Global Health Ingredients Market Trends and Insights
Growing Consumer Focus on Wellness and Disease Prevention Through Nutrition
According to the American Heart Association’s 2024 report, 29.3 million adults globally have been diagnosed with diabetes, 9.7 million remain undiagnosed, and 115.9 million are estimated to have pre-diabetes . This revelation is driving the growth of the global health ingredients market. As consumers become more proactive about their health, they're gravitating towards preventive, nutrition-centric solutions. This trend has heightened the demand for ingredients that boast clinically validated health benefits, transcending mere nutrition. For example, Kerry Group's Wellmune is known for bolstering immune health, while Nestlé Health Science's LactoSpore is recognized for its digestive benefits. With healthcare costs on the rise globally, many consumers are opting for dietary preventive measures instead of turning to costly treatments. In response to this trend, DSM-Firmenich has unveiled its Healthy Longevity platform, focusing on brain, digestive, and immune health. At the same time, wearable health technologies, such as Fitbit and Apple Watch, are enabling users to monitor their vitals and adjust their diets in real-time. This blend of health-centric lifestyles, scientifically backed formulations, and personalized monitoring is not just fueling market growth but also indicating a significant shift towards proactive health management through functional nutrition.
Increasing Prevalence of Chronic Diseases and Lifestyle Disorders
The increasing prevalence of chronic diseases is driving growth in the global health ingredients market. Factors such as sedentary lifestyles, poor dietary habits, and stress have increased the demand for preventive health solutions, including functional foods and dietary supplements containing bioactive ingredients. Consumers are taking a more active role in managing their health through nutrition, resulting in higher consumption of vitamins, minerals, and omega-3 fatty acids. These ingredients support immune function, reduce inflammation, and maintain cardiovascular, metabolic, and cognitive health. The transition from reactive to preventive healthcare approaches has expanded beyond consumer preferences to become a medical necessity. The rising number of chronic disease diagnoses has prompted individuals to seek natural and functional solutions for symptom management and disease prevention, sustaining the demand for health ingredients in food, beverage, and supplement products. According to the Italian National Institute of Statistics (ISTAT), in 2023, over 23.6 million individuals in Italy were living with at least one chronic disease, highlighting the need for dietary and lifestyle interventions .
Limited Availability of Raw Materials
As climate change disrupts traditional botanical cultivation zones and intensifies cross-industry demand, supply chain constraints significantly restrain the Global Health Ingredients Market. The geographic concentration of specialty ingredients, such as ashwagandha from India and ginseng from Korea, renders the supply chain vulnerable to extreme weather, geopolitical instability, and trade barriers. This vulnerability drives volatility in both the availability and pricing of these ingredients. In response, companies like ADM and Evonik are diversifying their sourcing and adopting alternative production methods, such as cellular agriculture and synthetic biology, to lessen their dependence on conventional farming. Yet, the industry's pivot towards sustainable sourcing, evidenced by certifications like Rainforest Alliance and FairWild, temporarily tightens supply as producers adapt to these environmental and social benchmarks. To bolster long-term stability, industry leaders are forging grower partnerships and investing in regional production hubs. A prime example is DSM-Firmenich's foray into localized fermentation facilities. Such strategies are pivotal for ensuring ingredient continuity and fostering global market growth, even in the face of escalating supply chain challenges.
Other drivers and restraints analyzed in the detailed report include:
- Growing Demand for Natural and Clean-Label Ingredients
- Aging Global Population Seeking Functional Foods
- Price Volatility of Natural and Organic Ingredients
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
In 2024, proteins commanded a dominant 30.15% share of the Global Health Ingredients Market, buoyed by a consistent consumer shift towards alternative protein sources. These proteins play pivotal roles in muscle health, weight management, and sports nutrition. The protein segment encompasses a diverse range: from plant-based options like pea and soy, to animal-derived choices such as whey and collagen, and even microbial sources like mycoprotein. Industry leaders, including DSM-Firmenich and Roquette, are pioneering specialized protein formulations tailored for various life stages and health conditions, notably targeting sarcopenia prevention in aging adults. Additionally, a rising demand for clean-label and allergen-free protein options is propelling segment growth in both developed and emerging markets.
Vitamins are on a rapid ascent, projected to grow at a CAGR of 8.95% through 2030. This surge is largely attributed to heightened awareness of micronutrient deficiencies and proactive fortification efforts, especially in Southeast Asia and Sub-Saharan Africa. While minerals enjoy steady traction in fortified foods and supplements, prebiotics and probiotics are witnessing a notable boom. This surge is driven by an intensified focus on gut health, immunity, and mental well-being, with brands like FrieslandCampina's Biotis and Chr. Hansen’s probiotic strains are leading the charge. Nutritional lipids, with a spotlight on algal omega-3s, are emerging as the go-to sustainable alternative to traditional fish oil. Meanwhile, niche segments like functional carbohydrates and enzymes are finding their footing, catering specifically to sports and digestive health. The “Others” category, which includes postbiotics and human milk oligosaccharides (HMOs), is also carving out a niche, showcasing promising growth despite its limited market share.
In 2024, plant-based ingredients commanded a leading share of 62.75%, fueled by a surging demand for natural, sustainable, and allergen-free substitutes to animal-derived components. This upward trajectory is bolstered by technological strides in extraction and purification, amplifying ingredient potency while upholding a clean-label image. Widely embraced in supplements and functional foods, ingredients like turmeric extract, pea protein, and green tea polyphenols are at the forefront. Industry giants, Kerry Group and Ingredion, have broadened their portfolios with plant-based offerings, aligning with both health and environmental standards, further cementing the segment's dominance.
Microbial-based ingredients are the fastest-growing segment, boasting a robust 9.12% CAGR (2025-2030). This surge is propelled by innovations in precision fermentation and synthetic biology, which either replicate or enhance compounds once exclusively sourced from plants or animals. Cargill's strategic forays into life sciences VC funds highlight a pronounced commitment to microbiome health and fermentation-derived actives. While animal-based ingredients still hold sway in niches requiring distinct bioactive profiles, they grapple with intensifying scrutiny over sustainability and ethical considerations. Meanwhile, the "Others" category, encompassing synthetic and hybrid formats, is making strides. Leveraging microencapsulation techniques like spray drying and coacervation, these formats safeguard bioactives and facilitate controlled release. The melding of biotechnology with traditional production methods unveils fresh avenues for nimble companies navigating a diverse ingredient landscape.
The Global Health Ingredients Market is Segmented by Product Type (Proteins, Vitamins, Minerals, and More), by Source (Plant-Based, Animal-Based, Microbial-Based, and Others), by Form (Dry, Liquid, and Others), by Application (Foods and Beverages, Dietary Supplements, Feed, Pharmaceuticals, and Others), and by Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).
Geography Analysis
In 2024, North America commanded the market, clinching a 35.78% share. This dominance is bolstered by robust regulatory frameworks, heightened consumer awareness of functional nutrition, and well-established distribution channels spanning the food, supplement, and pharmaceutical sectors. The region's vibrant research and development ecosystem, coupled with substantial venture capital influx, empowers biotechnology firms to spearhead innovations in ingredient synthesis and delivery technologies. These factors collectively position North America as a leader in driving advancements and meeting consumer demands in the health ingredients market.
On the other hand, the Asia-Pacific region is on a rapid ascent, boasting a projected CAGR of 10.45% through 2030. This surge is driven by urbanization, increasing disposable incomes, and a burgeoning middle class gravitating towards health-centric diets. While Japan stands out with its sophisticated functional food regulations, other emerging markets navigate through more streamlined approval processes. The region's dynamic growth is further supported by increasing investments in infrastructure and the rising influence of local manufacturers in the global market. Europe, with its stringent regulatory landscape, showcases a robust appetite for natural and organic products, underscoring a regional commitment to sustainability and ethical sourcing. European consumers are increasingly inclined to invest in ingredients that boast clinically validated benefits and transparent sourcing.
South America, the Middle East, and Africa are emerging as hotspots, spurred by urban expansion and a growing affinity for Western dietary trends. Yet, these regions grapple with regulatory hurdles and pricing dilemmas. Nonetheless, as their economies burgeon, so does the demand for health ingredients. These regions are also witnessing increased collaborations with global players, which are helping to address supply chain inefficiencies and improve market accessibility. Given the global interconnectivity of ingredient supply chains, the Asia-Pacific's upward trajectory is poised to sway global pricing and material accessibility, thereby redefining sourcing and distribution strategies worldwide.
List of Companies Covered in this Report:
- Archer-Daniels-Midland Company
- Cargill, Incorporated
- BASF SE
- Kerry Group
- DSM-Firmenich AG
- Ingredion Incorporated
- Corbion N.V.
- Glanbia plc
- Tate and Lyle PLC
- Lonza Group AG
- Evonik Industries AG
- Darling International Inc.
- Bio‑Botanica, Inc.
- Novozymes A/S
- Sabinsa Corporation
- Pharma Nord ApS
- Aker BioMarine
- Wörwag Pharma
- Certified Nutraceuticals
- Kemin Industries Inc.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
- 1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
- 2 RESEARCH METHODOLOGY
- 3 EXECUTIVE SUMMARY
- 4 MARKET LANDSCAPE
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Growing consumer focus on wellness and disease prevention through nutrition
- 4.2.2 Increasing prevalence of chronic diseases and lifestyle disorders
- 4.2.3 Growing demand for natural and clean-label ingredients
- 4.2.4 Aging global population seeking functional foods
- 4.2.5 Heightened demand for fortified food products
- 4.2.6 Increasing adoption of plant-based ingredients
- 4.3 Market Restraints
- 4.3.1 Limited availability of raw materials
- 4.3.2 Price volatility of natural and organic ingredients
- 4.3.3 Technical challenges in maintaining ingredient stability and shelf life
- 4.3.4 Complex regulatory requirements and approval processes across different regions
- 4.4 Supply Chain Analysis
- 4.5 Regulatory Landscape
- 4.6 Technological Outlook
- 4.7 Porter’s Five Forces
- 4.7.1 Threat of New Entrants
- 4.7.2 Bargaining Power of Buyers
- 4.7.3 Bargaining Power of Suppliers
- 4.7.4 Threat of Substitutes
- 4.7.5 Competitive Rivalry
- 5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
- 5.1 By Product Type
- 5.1.1 Proteins
- 5.1.2 Vitamins
- 5.1.3 Minerals
- 5.1.4 Prebiotics
- 5.1.5 Nutritional Lipids
- 5.1.6 Probiotics
- 5.1.7 Functional Carbohydrates
- 5.1.8 Enzymes
- 5.1.9 Others
- 5.2 By Source
- 5.2.1 Plant-based
- 5.2.2 Animal -based
- 5.2.3 Microbial-based
- 5.2.4 Others
- 5.3 By Form
- 5.3.1 Dry
- 5.3.2 Liquid
- 5.3.3 Others
- 5.4 By Application
- 5.4.1 Foods and Beverages
- 5.4.1.1 Bakery and Confectionary
- 5.4.1.2 Snacks
- 5.4.1.3 Dairy Products
- 5.4.1.4 Beverages
- 5.4.1.5 Others
- 5.4.2 Dietary Supplements
- 5.4.3 Feed
- 5.4.4 Pharmaceuticals
- 5.4.5 Others
- 5.5 By Geography
- 5.5.1 North America
- 5.5.1.1 United States
- 5.5.1.2 Canada
- 5.5.1.3 Mexico
- 5.5.1.4 Rest of North America
- 5.5.2 Europe
- 5.5.2.1 Germany
- 5.5.2.2 United Kingdom
- 5.5.2.3 Italy
- 5.5.2.4 France
- 5.5.2.5 Spain
- 5.5.2.6 Netherlands
- 5.5.2.7 Poland
- 5.5.2.8 Belgium
- 5.5.2.9 Sweden
- 5.5.2.10 Rest of Europe
- 5.5.3 Asia-Pacific
- 5.5.3.1 China
- 5.5.3.2 India
- 5.5.3.3 Japan
- 5.5.3.4 Australia
- 5.5.3.5 Indonesia
- 5.5.3.6 South Korea
- 5.5.3.7 Thailand
- 5.5.3.8 Singapore
- 5.5.3.9 Rest of Asia-Pacific
- 5.5.4 South America
- 5.5.4.1 Brazil
- 5.5.4.2 Argentina
- 5.5.4.3 Colombia
- 5.5.4.4 Chile
- 5.5.4.5 Peru
- 5.5.4.6 Rest of South America
- 5.5.5 Middle East and Africa
- 5.5.5.1 South Africa
- 5.5.5.2 Saudi Arabia
- 5.5.5.3 United Arab Emirates
- 5.5.5.4 Nigeria
- 5.5.5.5 Egypt
- 5.5.5.6 Morocco
- 5.5.5.7 Turkey
- 5.5.5.8 Rest of Middle East and Africa
- 6 COMPETITIVE LANDSCAPE
- 6.1 Market Concentration
- 6.2 Strategic Moves
- 6.3 Market Share Analysis
- 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
- 6.4.1 Archer-Daniels-Midland Company
- 6.4.2 Cargill, Incorporated
- 6.4.3 BASF SE
- 6.4.4 Kerry Group
- 6.4.5 DSM-Firmenich AG
- 6.4.6 Ingredion Incorporated
- 6.4.7 Corbion N.V.
- 6.4.8 Glanbia plc
- 6.4.9 Tate and Lyle PLC
- 6.4.10 Lonza Group AG
- 6.4.11 Evonik Industries AG
- 6.4.12 Darling International Inc.
- 6.4.13 Bio‑Botanica, Inc.
- 6.4.14 Novozymes A/S
- 6.4.15 Sabinsa Corporation
- 6.4.16 Pharma Nord ApS
- 6.4.17 Aker BioMarine
- 6.4.18 Wörwag Pharma
- 6.4.19 Certified Nutraceuticals
- 6.4.20 Kemin Industries Inc.
- 7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK
Pricing
Currency Rates